Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated:  1/11/2016
Dr. Joseph Frasca
mi
from
Adelaide,
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Dr. Joseph Frasca
mi
from
Adelaide,
Click here to add this to my saved trials
Migraine and Body Composition
Migraine and Body Composition
Status: Enrolling
Updated:  1/27/2016
The Johns Hopkins Bayview Headache Center
mi
from
Baltimore, MD
Migraine and Body Composition
Migraine and Body Composition
Status: Enrolling
Updated: 1/27/2016
The Johns Hopkins Bayview Headache Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Equity in Diagnostic Imaging Trial
Equity in Diagnostic Imaging Trial (EDIT)
Status: Enrolling
Updated:  1/28/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Equity in Diagnostic Imaging Trial
Equity in Diagnostic Imaging Trial (EDIT)
Status: Enrolling
Updated: 1/28/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers
Status: Enrolling
Updated:  2/2/2016
Prism Research
mi
from
St. Paul, MN
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers
Status: Enrolling
Updated: 2/2/2016
Prism Research
mi
from
St. Paul, MN
Click here to add this to my saved trials
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
A Phase I, Open Label, Single-Dose, Four-Way Crossover Study Comparing the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
Status: Enrolling
Updated:  2/2/2016
MD Clinic
mi
from
Hallandale Beach, FL
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
A Phase I, Open Label, Single-Dose, Four-Way Crossover Study Comparing the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
Status: Enrolling
Updated: 2/2/2016
MD Clinic
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Phoenix, AZ
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Little Rock, AR
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Newport Beach, CA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
San Francisco, CA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Fairfield, CT
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Fairfield, CT
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Ocala, FL
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Sunrise, FL
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Atlanta, GA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Columbus, GA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Decatur, GA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Savannah, GA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Chicago, IL
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Springfield, MO
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
St. Louis, MO
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Mount Vernon, NY
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Mount Vernon, NY
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Plainview, NY
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Plainview, NY
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Greensboro, NC
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
West Chester, OH
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
West Chester, OH
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Philadelphia, PA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Wynnewood, PA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Wynnewood, PA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Memphis, TN
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Nashville, TN
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Dallas, TX
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Houston, TX
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
San Antonio, TX
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Alexandria, VA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Seattle, WA
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
The Efficacy and Tolerability of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Phoenix, AZ
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Little Rock, AR
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Newport Beach, CA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
San Francisco, CA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Fairfield, CT
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Fairfield, CT
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Ocala, FL
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Sunrise, FL
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Atlanta, GA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated:  2/2/2016
Clinical Research Facility
mi
from
Columbus, GA
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Status: Enrolling
Updated: 2/2/2016
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials